Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 1.00 |
| ▸ | PKM | P14618 | 3/20 | 1.00 |
| ▸ | CA12 | O43570 | 2/20 | 1.00 |
| ▸ | CA1 | P00915 | 2/20 | 1.00 |
| ▸ | CA2 | P00918 | 2/20 | 1.00 |
| ▸ | CA3 | P07451 | 2/20 | 1.00 |
| ▸ | CA4 | P22748 | 2/20 | 1.00 |
| ▸ | CA6 | P23280 | 2/20 | 1.00 |
| ▸ | CA5A | P35218 | 2/20 | 1.00 |
| ▸ | SNCA | P37840 | 2/20 | 1.00 |
| ▸ | CA7 | P43166 | 2/20 | 1.00 |
| ▸ | CA9 | Q16790 | 2/20 | 1.00 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 1.00 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 1.00 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 1.00 |
| ▸ | CSNK2B | P67870 | 1/20 | 1.00 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 1.00 |
| ▸ | CSNK2A3 | Q8NEV1 | 1/20 | 1.00 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.79 |
| ▸ | NFKB1 | P19838 | 3/20 | 0.79 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ferulate SCHEMBL15673 | 1.00 | KDM4E (1.00) | KDM4EPKMCA12CA1CA2 | |
| Ferulate SCHEMBL1908219 | 1.00 | KDM4E (1.00) | KDM4EPKMCA12CA1CA2 | |
| Ferulate SCHEMBL30210805 | 1.00 | KDM4E (1.00) | KDM4EPKMCA12CA1CA2 | |
| Ferulate SCHEMBL29365367 | 1.00 | KDM4E (1.00) | KDM4EPKMCA12CA1CA2 | |
| Ferulate SCHEMBL1703377 | 1.00 | KDM4E (1.00) | KDM4EPKMCA12CA1CA2 | |
| Ferulate SCHEMBL15674 | 1.00 | KDM4E (1.00) | KDM4EPKMCA12CA1CA2 | |
| Ferulate SCHEMBL30760602 | 1.00 | KDM4E (1.00) | KDM4EPKMCA12CA1CA2 | |
| Ferulate SCHEMBL29481134 | 1.00 | KDM4E (1.00) | KDM4EPKMCA12CA1CA2 | |
| Ferulate SCHEMBL30880441 | 1.00 | KDM4E (1.00) | KDM4EPKMCA12CA1CA2 | |
| Ferulate SCHEMBL1908222 | 1.00 | KDM4E (1.00) | KDM4EPKMCA12CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 666 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260096574-A1 | CHOCOLATE REPLICAS PRODUCED FROM INDIVIDUAL COMPONENTS | VOYAGE FOODS INC (US) | 2026-04-09 | — | — | US | claimed |
| US-20260091047-A1 | THERAPEUTIC COMBINATIONS FOR MOVEMENT DISORDERS | NATIVE CODE BIO LLC (US) | 2026-04-02 | — | — | US | claimed |
| US-20260007144-A1 | CHOCOLATE REPLICAS PRODUCED FROM INDIVIDUAL COMPONENTS | VOYAGE FOODS INC (US) | 2026-01-08 | — | — | US | claimed |
| EP-4606226-A2 | CHOCOLATE REPLICAS PRODUCED FROM INDIVIDUAL COMPONENTS | Voyage Foods, Inc. (US) | 2025-08-27 | — | — | EP | claimed |
| US-12385071-B2 | Methods for the production of ferulic acid | INVENTURE RENEWABLES, INC. (US) | 2025-08-12 | — | — | US | claimed |
| EP-4583856-A2 | THERAPEUTIC COMBINATIONS FOR MOVEMENT DISORDERS | Native Code Bio, LLC (US) | 2025-07-16 | — | — | EP | claimed |
| US-12350296-B2 | Liquid propolis extract, its formulation and use thereof | ApiotiX Technologies d.o.o. (HR) | 2025-07-08 | — | — | US | claimed |
| EP-4578292-A1 | CHOCOLATE REPLICAS PRODUCED FROM INDIVIDUAL COMPONENTS | Voyage Foods, Inc. (US) | 2025-07-02 | — | — | EP | claimed |
| CN-119926183-A | Sulfonated GO molecularly imprinted polymer composite membrane and preparation method and application thereof | 季华实验室 | 2025-05-06 | — | — | CN | claimed |
| CN-119081005-B | Trans-ferulic acid difunctional monomer molecularly imprinted polymer and preparation method and application thereof | 季华实验室 | 2025-04-15 | — | — | CN | claimed |
| WO-2022141375-A1 | COMPOSITION FOR CARING FOR KERTATIN MATERIALS | L'OREAL (FR) | 2022-07-07 | — | — | WO | claimed |
| US-20220177403-A1 | REACTIVE SURFACTANTS | STEPAN COMPANY | 2022-06-09 | — | — | US | claimed |
| CN-114535861-A | High-adhesion lead-free soldering paste for packaging and preparation method thereof | 深圳市同方电子新材料有限公司 | 2022-05-27 | — | — | CN | claimed |
| CN-114478664-A | Chemical synthesis method of trans-ferulic acid-4-glucoside | 北京岳达生物科技有限公司 | 2022-05-13 | — | — | CN | claimed |
| US-20220133810-A1 | LIQUID PROPOLIS EXTRACT, ITS FORMULATION AND USE THEREOF | ApiotiX Technologies d.o.o. (HR) | 2022-05-05 | — | — | US | claimed |
| CN-114423294-A | Coffee replica made from individual components | 航行食品股份有限公司 | 2022-04-29 | — | — | CN | claimed |
| US-20220112451-A1 | BOURBON REPLICAS PRODUCED FROM INDIVIDUAL COMPONENTS | AVA FOOD LABS, INC. | 2022-04-14 | — | — | US | claimed |
| CN-114260020-A | Preparation method and application of carbon nitride modified carbon nanotube composite material | 嘉兴学院 | 2022-04-01 | — | — | CN | claimed |
| CN-114195691-A | Amide-containing ferulic acid derivative and preparation method and application thereof | 贵州大学 | 2022-03-18 | — | — | CN | claimed |
| CN-109152404-B | Enhanced functionality desalted nutritional compositions from halophytes and methods of making the same | 派图有限公司 | 2022-03-15 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260007144-A1 | CHOCOLATE REPLICAS PRODUCED FROM INDIVIDUAL COMPONENTS | HAAO, PTGES2, PTGES | KDM4E 331/4885PKM 1785/4885CA12 406/4885 |
| US-20260091047-A1 | THERAPEUTIC COMBINATIONS FOR MOVEMENT DISORDERS | HMBS, SNCA, PYGB | KDM4E 1322/4885PKM 1072/4885CA12 2296/4885 |
| US-12350296-B2 | Liquid propolis extract, its formulation and use thereof | CUTA, LITAF, ALB | KDM4E 2763/4885PKM 4266/4885CA12 1674/4885 |
| US-20220177403-A1 | REACTIVE SURFACTANTS | SMURF1, STS, ESD | KDM4E 3448/4885PKM 3283/4885CA12 3968/4885 |
| US-20260096574-A1 | CHOCOLATE REPLICAS PRODUCED FROM INDIVIDUAL COMPONENTS | HAAO, HTR6, SCD | KDM4E 95/4885PKM 1808/4885CA12 1152/4885 |
| US-20220133810-A1 | LIQUID PROPOLIS EXTRACT, ITS FORMULATION AND USE THEREOF | CUTA, LITAF, ALB | KDM4E 2763/4885PKM 4266/4885CA12 1674/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.